Considering the induction of iNOS, COX-2 has been reported to be involved in the disruption of BBB [40], our findings suggest that the activation of microglia and cytokine expression contribute to HMGB1-induced BBB disruption and HT development after thrombolysis in ischemic stroke. The gene discussed is HMGB1; the disease is hematocrit.